An Open-label, Escalating Dose Study to Assess the Safety, Tolerability and Dose-range Finding of a Single Intrathecal Dose of ISIS 396443 in Patients With Spinal Muscular Atrophy
收藏DataCite Commons2025-06-01 更新2026-05-07 收录
下载链接:
https://search.vivli.org/doiLanding/studies/00002890/isLanding
下载链接
链接失效反馈官方服务:
资源简介:
This objectives of this study are to evaluate the safety, tolerability, and pharmacokinetics of a single dose of nusinersen (ISIS 396443) administered intrathecally to participants with Spinal Muscular Atrophy (SMA).
提供机构:
Vivli
创建时间:
2018-10-27



